Literature DB >> 1086742

A streptomycin-sensitive revertant of a streptomycin-dependent strain of Vibrio cholerae.

V B Sinha, J W Bhattacharjee.   

Abstract

A study was made of a streptomycin-sensitive revertant of a streptomycin-dependent strain of V. cholerae. The revertant, designated as strain KB599, appears to be avirulent in animal experimental models. However, no evidence of multiplication was found in infant mice.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1086742      PMCID： PMC2366534     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


  5 in total

1.  CHOLERA VACCINES AND PLACENTAL TRANSMISSION OF ANTIBODIES.

Authors:  M V PANSE; N K DUTTA
Journal:  J Immunol       Date:  1964-08       Impact factor: 5.422

2.  Experimental cholera in infant rabbits: a method for chemotherapeutic investigation.

Authors:  N K DUTTA; M K HABBU
Journal:  Br J Pharmacol Chemother       Date:  1955-06

3.  Pathogenicity and antigenicity of streptomycin dependent mutants of Vibrio comma (types: Inaba and Ogawa).

Authors:  A L OLITZKI; Z OLITZKI
Journal:  Exp Med Surg       Date:  1955

4.  Studies on toxinogenesis in Vibrio cholerae. I. Isolation of mutants with altered toxinogenicity.

Authors:  R A Finkelstein; M L Vasil; R K Holmes
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

5.  Experimental cholera in infant mice: protective effects of antibody.

Authors:  W Chaicumpa; D Rowley
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226
  5 in total
  2 in total

1.  Attenuated recombinant strains of Vibrio cholerae for oral immunization.

Authors:  B S Srivastava; V B Sinha; R Srivastava
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  Isolation and phenotypic characterization of virulence-deficient mutants of Vibrio cholerae.

Authors:  V S Baselski; S Upchurch; C D Parker
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.